AATB is thrilled to invite you to exhibit at AATB Congress 26, taking place October 4–7 in San Francisco, CA! 

AATB commends Representatives Debbie Dingell (D-MI) and Rich McCormick, MD (R-GA) for writing to Acting FDA Commissioner Kyle Diamantas regarding the agency’s policy on screening human tissue donors for sepsis.

Skin substitute reimbursement has been a challenging issue for our industry, and it has remained one of AATB’s top advocacy priorities.

AATB will present a one-time honor recognizing 50 individuals whose leadership, service, innovation, and dedication have helped shape the Association throughout its history and have influenced what AATB has become today.

As previously communicated to the full AATB membership, governance changes approved by the AATB voting membership have restructured the organization.

We're excited to announce that registration is now open for the 2026 BCA Networking Conference, featuring an exclusive AATB Tissue Track!

AATB recently submitted a comment letter to the US Food and Drug Administration (FDA) regarding the agency’s 2007 donor eligibility guidance, which determined that sepsis is a relevant communicable disease agent or disease (RCDAD).

The AATB Processing and Distribution Council's Supply Chain Workgroup would like to inform AATB members about the potential impact of a recent cyber-attack on Stryker, a global medical device and surgical instrument manufacturer. The attack, attributed to an Iran-linked hacktivist group, has caused disruptions to Stryker’s information systems, impacting order processing, production, and shipping operations.

The House Appropriations Committee has set deadlines for Members of Congress to submit appropriations requests.